BioNexus Gene Lab (BGLC) EBITDA Margin (2018 - 2026)
BioNexus Gene Lab's (BGLC) quarterly EBITDA Margin came in at 370.81% in Q2 2026, down 34377.0% year-over-year from N/an in Q2 2025, and up 84.33% quarter-over-quarter from 2366.21% in Q1 2026.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) EBITDA Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has disclosed EBITDA Margin across 9 years of filings, most recently posting 370.81% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 34377.0% year-over-year to 370.81%; the TTM figure through Jun 2026 stood at 81.82% (down 5059.0% YoY), while the FY2025 annual figure was 39.93%, down 2339.0% from the prior year.
- EBITDA Margin came in at 370.81% for Q2 2026 at BioNexus Gene Lab, up from 2366.21% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 13.13% in Q2 2024 to a low of 2366.21% in Q1 2026.
- Average EBITDA Margin over 5 years is 177.96%, with a median of 13.55% recorded in 2023.
- Year-over-year, EBITDA Margin surged 4816 bps in 2024 and plunged 233727 bps in 2026.
- Over 5 years, EBITDA Margin stood at 4.32% in 2022, then surged by 362 bps to 11.34% in 2023, then tumbled by 245 bps to 16.49% in 2024, then slumped by 1195 bps to 213.5% in 2025, then slumped by 74 bps to 370.81% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 370.81% in Q2 2026, 2366.21% in Q1 2026, and 213.5% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 62.38 Bn | 62.17 Bn | 1.98 Bn | 16.07% |
| 2 | Fastenal | 56.92 Bn | 56.71 Bn | 1.06 Bn | 21.02% |
| 3 | Ferguson Enterprises | 44.34 Bn | 43.52 Bn | 2.32 Bn | 8.19% |
| 4 | Reliance | 20.45 Bn | 20.23 Bn | 1.30 Bn | 9.54% |
| 5 | Wesco International | 17.12 Bn | 16.31 Bn | 1.46 Bn | 5.73% |
| 6 | Applied Industrial Technologies | 11.98 Bn | 11.86 Bn | 411.22 Mn | 11.78% |
| 7 | Watsco | 11.22 Bn | 11.23 Bn | 578.93 Mn | 11.32% |
| 8 | Avantor | 10.13 Bn | 9.82 Bn | 537.00 Mn | 7.20% |
| 9 | Core & Main | 8.33 Bn | 8.25 Bn | 520.00 Mn | 9.79% |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | -370.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -370.81% |
| Mar 31, 2026 | -2,366.21% |
| Dec 31, 2025 | -213.50% |
| Sep 30, 2025 | -27.62% |
| Jun 30, 2025 | -27.05% |
| Mar 31, 2025 | -28.94% |
| Dec 31, 2024 | -16.49% |
| Sep 30, 2024 | -50.85% |
| Jun 30, 2024 | 13.13% |
| Mar 31, 2024 | -3.32% |
| Dec 31, 2023 | 11.34% |
| Sep 30, 2023 | -99.01% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -2.13% |
| Dec 31, 2022 | -4.32% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -5.55% |
| Mar 31, 2022 | 1.15% |
| Dec 31, 2021 | 6.20% |
| Sep 30, 2021 | 10.42% |